New RSV vaccine called Arexy approved for people aged 60 and older
Health Canada has authorized the first RSV vaccine for people aged 60 and older.
Doctors have been calling for the vaccine for this group, which is at a higher risk of becoming severely ill from the virus.
Drugmaker GSK says during clinical trials, the drug was 82 percent effective at lowering respiratory tract disease caused by RSV.
In Canada, RSV season usually starts in the fall, and ends in the spring.

GM Investing in St. Catharines
NRP Investigating Fatal Pelham Crash
NRP Officers Praised by Management
945 Supportive Housing Units Approved
Niagara Talks Canadian Defense
Niagara Falls Expecting More Evacuees
St. Catharines Man Charged with Voyuerism
Candidate Registration Approaches